233 related articles for article (PubMed ID: 8756701)
21. Interactions of factor XIII with fibrin as substrate and cofactor.
Hornyak TJ; Shafer JA
Biochemistry; 1992 Jan; 31(2):423-9. PubMed ID: 1731900
[TBL] [Abstract][Full Text] [Related]
22. The zymogen forms of blood coagulation factor XIII bind specifically to fibrinogen.
Greenberg CS; Shuman MA
J Biol Chem; 1982 Jun; 257(11):6096-101. PubMed ID: 7076665
[TBL] [Abstract][Full Text] [Related]
23. Studies on the structural abnormality of fibrinogen Paris I.
Mosesson MW; Amrani DL; Ménaché D
J Clin Invest; 1976 Mar; 57(3):782-90. PubMed ID: 1249208
[TBL] [Abstract][Full Text] [Related]
24. The role of gamma A/gamma ' fibrinogen in plasma factor XIII activation.
Moaddel M; Falls LA; Farrell DH
J Biol Chem; 2000 Oct; 275(41):32135-40. PubMed ID: 10913112
[TBL] [Abstract][Full Text] [Related]
25. Crosslinking kinetics of the human transglutaminase, factor XIII[A2], acting on fibrin gels and gamma-chain peptides.
Lewis KB; Teller DC; Fry J; Lasser GW; Bishop PD
Biochemistry; 1997 Feb; 36(5):995-1002. PubMed ID: 9033388
[TBL] [Abstract][Full Text] [Related]
26. b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII.
Mary A; Achyuthan KE; Greenberg CS
Biochim Biophys Acta; 1988 Sep; 966(3):328-35. PubMed ID: 2901275
[TBL] [Abstract][Full Text] [Related]
27. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
[TBL] [Abstract][Full Text] [Related]
28. A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2).
Katona E; Haramura G; Kárpáti L; Fachet J; Muszbek L
Thromb Haemost; 2000 Feb; 83(2):268-73. PubMed ID: 10739385
[TBL] [Abstract][Full Text] [Related]
29. Noncatalytic subunits of human blood plasma coagulation factor XIII. Preparation and partial characterization of modified forms.
Seelig GF; Folk JE
J Biol Chem; 1980 Sep; 255(18):8881-6. PubMed ID: 7410400
[TBL] [Abstract][Full Text] [Related]
30. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of human fibrinogen.
Kollman JM; Pandi L; Sawaya MR; Riley M; Doolittle RF
Biochemistry; 2009 May; 48(18):3877-86. PubMed ID: 19296670
[TBL] [Abstract][Full Text] [Related]
32. The role of ascorbate and histidine in fibrinogen protection against changes following exposure to a sterilizing dose of gamma-irradiation.
Zbikowska HM; Nowak P; Wachowicz B
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):669-76. PubMed ID: 17890955
[TBL] [Abstract][Full Text] [Related]
33. [Identification of a (D-D)...E complex in degradation products of bovine fibrin stabilized by factor XIII].
Hudry-Clergeon G; Paturel L; Suscillon M
Pathol Biol (Paris); 1974 Nov; 22 suppl():47-52. PubMed ID: 4620095
[No Abstract] [Full Text] [Related]
34. The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits.
Byrnes JR; Wilson C; Boutelle AM; Brandner CB; Flick MJ; Philippou H; Wolberg AS
Blood; 2016 Oct; 128(15):1969-1978. PubMed ID: 27561317
[TBL] [Abstract][Full Text] [Related]
35. [Effect of anesthesia on blood coagulation factor XIII].
Homann B; Blumenberg D; Lerner H
Anaesthesist; 1984 Mar; 33(3):145-8. PubMed ID: 6721127
[TBL] [Abstract][Full Text] [Related]
36. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
[TBL] [Abstract][Full Text] [Related]
37. Structural and chromatographic heterogeneity of normal plasma fibrinogen associated with the presence of three gamma-chain types with distinct molecular weights.
Francis CW; Kraus DH; Marder VJ
Biochim Biophys Acta; 1983 Apr; 744(2):155-64. PubMed ID: 6404305
[TBL] [Abstract][Full Text] [Related]
38. Reactivity of fibrinogen crosslinking sites in the absence of thrombin.
Seelich T; Furlan M; Beck EA
Thromb Haemost; 1976 Jun; 35(3):620-7. PubMed ID: 10637
[TBL] [Abstract][Full Text] [Related]
39. Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma factor XIII.
Greenberg CS; Achyuthan KE; Fenton JW
Blood; 1987 Mar; 69(3):867-71. PubMed ID: 2880615
[TBL] [Abstract][Full Text] [Related]
40. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides.
Isetti G; Maurer MC
Biochemistry; 2004 Apr; 43(14):4150-9. PubMed ID: 15065858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
